COZADD BRUCE C — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

COZADD BRUCE C has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $8.91M.

Profile

COZADD BRUCE C

Bruce C. Cozadd is the Chairman and CEO of Jazz Pharmaceuticals, a biopharmaceutical company focused on treatments for sleep disorders and oncology. He has played a significant role in the company's growth and strategic acquisitions, including the purchase of GW Pharmaceuticals.

RoleDirector
Notability60/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-06JAZZJazz Pharmaceuticals plcS — Open-market sale6.0K$240.47$1.44M
2026-06-03JAZZJazz Pharmaceuticals plcS — Open-market sale6.0K$235.12$1.41M
2026-05-05JAZZJazz Pharmaceuticals plcS — Open-market sale6.0K$203.33$1.22M
2026-04-03JAZZJazz Pharmaceuticals plcS — Open-market sale [10b5-1]24$191.74$5K
2026-04-03JAZZJazz Pharmaceuticals plcS — Open-market sale [10b5-1]2.3K$190.94$438K
2026-04-03JAZZJazz Pharmaceuticals plcS — Open-market sale [10b5-1]3.7K$190.22$701K
2026-03-09JAZZJazz Pharmaceuticals plcF — Tax withholding / forfeiture15.1K$188.69$2.85M
2026-03-04JAZZJazz Pharmaceuticals plcS — Open-market sale [10b5-1]233$187.84$44K
2026-03-04JAZZJazz Pharmaceuticals plcS — Open-market sale [10b5-1]2.6K$186.73$487K
2026-03-04JAZZJazz Pharmaceuticals plcS — Open-market sale [10b5-1]3.2K$186.09$588K
2026-01-22JAZZJazz Pharmaceuticals plcF — Tax withholding / forfeiture17.5K$171.16$2.99M
2026-01-22JAZZJazz Pharmaceuticals plcA — Grant or award35.9K$0.00
2025-10-01JAZZJazz Pharmaceuticals plcS — Open-market sale3.5K$140.00$490K
2025-10-01JAZZJazz Pharmaceuticals plcS — Open-market sale2.0K$131.78$264K
2025-09-14JAZZJazz Pharmaceuticals plcF — Tax withholding / forfeiture15.6K$126.16$1.97M
2025-09-02JAZZJazz Pharmaceuticals plcS — Open-market sale3.0K$130.00$390K
2025-09-02JAZZJazz Pharmaceuticals plcS — Open-market sale3.0K$127.23$382K
2025-08-01JAZZJazz Pharmaceuticals plcS — Open-market sale1.0K$113.21$113K
2025-07-01JAZZJazz Pharmaceuticals plcS — Open-market sale500$110.00$55K
2025-07-01JAZZJazz Pharmaceuticals plcS — Open-market sale500$105.26$53K

Companies — Last 90 Days

Frequently Asked Questions

Who is COZADD BRUCE C?

Bruce C. Cozadd is the Chairman and CEO of Jazz Pharmaceuticals, a biopharmaceutical company focused on treatments for sleep disorders and oncology. He has played a significant role in the company's growth and strategic acquisitions, including the purchase of GW Pharmaceuticals.…

How many SEC Form 4 filings has COZADD BRUCE C submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has COZADD BRUCE C been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 23 open-market sales ($8.91M) across all tracked filings.

Where can I see all of COZADD BRUCE C's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live COZADD BRUCE C profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.